Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy.
Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy.
复制标题
DOI:
10.1016/j.cmet.2015.11.002
复制
发表时间:
2016-01-12
期刊:
影响因子:
29
通讯作者:
Restifo NP
中科院分区:
文献类型:
--
作者:
Sukumar M;Liu J;Mehta GU;Patel SJ;Roychoudhuri R;Crompton JG;Klebanoff CA;Ji Y;Li P;Yu Z;Whitehill GD;Clever D;Eil RL;Palmer DC;Mitra S;Rao M;Keyvanfar K;Schrump DS;Wang E;Marincola FM;Gattinoni L;Leonard WJ;Muranski P;Finkel T;Restifo NP
Long-term survival and anti-tumor immunity of adoptively-transferred CD8+ T cells is dependent on their metabolic fitness, but approaches to isolate therapeutic T cells based on metabolic features are not well established. Here we utilized a lipophilic cationic dye tetramethylrhodamine methyl ester (TMRM) to identify and isolate metabolically-robust T cells based on their mitochondrial membrane potential (ΔΨm). Comprehensive metabolomic and gene expression profiling demonstrated global features of improved metabolic fitness in low-ΔΨm-sorted CD8+ T cells. Transfer of these low-ΔΨm T cells was associated with superior long-term in vivo persistence and an enhanced capacity to eradicate established tumors compared with high-ΔΨm cells. Use of ΔΨm-based sorting to enrich for cells with superior metabolic features was observed in CD8+, CD4+ T-cell subsets and long-term hematopoietic stem cells. This metabolism-based approach to cell-selection may be broadly applicable to therapies involving the transfer of HSC or lymphocytes for the treatment of viral-associated illnesses and cancer.